2000-01-27T00:00:00
Money would be better spent on alternative ways of improving quality of life in people with secondary progressive multiple sclerosis than on the drug beta interferon, according to research conducted in Scotland.
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud